Income Statement Ind-Swift Laboratories Limited

Stocks

INDSWFTLAB

INE915B01019

Pharmaceuticals

Market Closed - NSE India S.E. 04:35:08 12/08/2026 pm IST			5-day change	1st Jan Change
300.00 ^INR	+5.38%		+30.32%	+240.33%

10/08	Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
10/07	Ind-Swift Laboratories Limited announced that it expects to receive INR 343 million in funding	CI

8a698ef.Zl2Sg7Dnzbn0-2ZhJ85uudjNi_qYkT0y5f2tdWnFOzo.EgjUt8Teh8-8sRUwS_ko6oqK0cnRvHdckbqdEgONa3wkOOuu16OB9seLVg

Published financial data: IND-SWIFT LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	891.34Cr	1.04TCr	1.21TCr	1.28TCr	561.71Cr
Other Revenues, Total	15Cr	13Cr	8.62Cr	16Cr	-
Total Revenues	906.78Cr	1.05TCr	1.22TCr	1.3TCr	561.71Cr
Cost of Goods Sold, Total	451.45Cr	526.59Cr	655.58Cr	661.46Cr	287.95Cr
Gross Profit	455.33Cr	525.54Cr	560.35Cr	635.8Cr	273.76Cr
Selling General & Admin Expenses, Total	107.85Cr	115.1Cr	140.08Cr	158.23Cr	125.17Cr
Depreciation & Amortization - (IS)	87Cr	131.04Cr	57Cr	53Cr	24Cr
Other Operating Expenses	149.22Cr	186.98Cr	181.39Cr	209.23Cr	167.97Cr
Other Operating Expenses, Total	344.37Cr	433.13Cr	378.83Cr	420.77Cr	317.62Cr
Operating Income	110.96Cr	92Cr	181.52Cr	215.03Cr	-44Cr
Interest Expense, Total	-93Cr	-91Cr	-86Cr	-47Cr	-1.38Cr
Interest And Investment Income	51.28L	56.21L	5.87Cr	18Cr	38Cr
Net Interest Expenses	-93Cr	-91Cr	-81Cr	-28Cr	37Cr
Income (Loss) On Equity Invest.	-	-	-23.42L	-49.01L	-5L
Currency Exchange Gains (Loss)	3.27Cr	15Cr	18Cr	11Cr	10Cr
Other Non Operating Income (Expenses)	-3.38Cr	9.92Cr	-4.86Cr	-4.33Cr	2.54Cr
EBT, Excl. Unusual Items	18Cr	26Cr	114Cr	192.44Cr	5.82Cr
Gain (Loss) On Sale Of Assets	-	-6.57Cr	-6L	2.23Cr	29Cr
Asset Writedown	-	-7.1Cr	-1Cr	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-27Cr	386.59Cr	223.2Cr
EBT, Incl. Unusual Items	18Cr	13Cr	86Cr	581.27Cr	257.75Cr
Income Tax Expense	21Cr	15Cr	39Cr	160.31Cr	7.27Cr
Earnings From Continuing Operations	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Net Income to Company	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Net Income - (IS)	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Net Income to Common Excl. Extra Items	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Per Share Items
Net EPS - Basic	-0.53	-0.36	8.06	71.24	37.25
Basic EPS - Continuing Operations	-0.53	-0.36	8.06	71.24	37.25
Basic Weighted Average Shares Outstanding	5.91Cr	5.91Cr	5.91Cr	5.91Cr	6.72Cr
Net EPS - Diluted	-0.53	-0.36	8.06	71.24	35.21
Diluted EPS - Continuing Operations	-0.53	-0.36	8.06	71.24	35.21
Diluted Weighted Average Shares Outstanding	5.91Cr	5.91Cr	5.91Cr	5.91Cr	7.11Cr
Normalized Basic EPS	1.9	2.77	12.06	20.36	0.54
Normalized Diluted EPS	1.9	2.77	12.06	20.36	0.51
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	166.1Cr	222.37Cr	238.86Cr	268.31Cr	-22Cr
EBITA	110.96Cr	92Cr	181.52Cr	215.03Cr	-44Cr
EBIT	110.96Cr	92Cr	181.52Cr	215.03Cr	-44Cr
EBITDAR	166.64Cr	222.88Cr	239.6Cr	269.18Cr	-20Cr
Total Revenues (As Reported)	914.04Cr	1.08TCr	1.24TCr	1.33TCr	643.09Cr
Effective Tax Rate - (Ratio)	117.48	117.15	44.84	27.58	2.82
Total Current Taxes	12Cr	25Cr	15Cr	171.09Cr	7.74Cr
Total Deferred Taxes	9.48Cr	-11Cr	23Cr	-11Cr	-3.82Cr
Normalized Net Income	11Cr	16Cr	71Cr	120.28Cr	3.64Cr
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	91Cr	89Cr	84Cr	45Cr	1.38Cr
Non-Cash Pension Expense	77.95L	87.39L	87.39L	1.34Cr	71.87L
Supplemental Operating Expense Items
Advertising Expense	76.58L	23.58L	3.49Cr	4.55Cr	6.02Cr
Selling and Marketing Expenses	76.58L	23.58L	3.49Cr	4.55Cr	6.02Cr
Research And Development Expense From Footnotes	33Cr	33Cr	43Cr	36Cr	2.3Cr
Net Rental Expense, Total	53.71L	51.58L	74.51L	86.39L	1.64Cr
Imputed Operating Lease Interest Expense	39.39L	38.54L	56.74L	73.45L	14.04L
Imputed Operating Lease Depreciation	14.32L	13.04L	17.77L	12.94L	1.49Cr
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	12Cr	21Cr	18Cr	431.93Cr	428.04Cr
Short Term Investments	-	-	-	-	39Cr
Total Cash And Short Term Investments	12Cr	21Cr	18Cr	431.93Cr	467.4Cr
Accounts Receivable, Total	432.39Cr	454.78Cr	505.32Cr	169.12Cr	164.52Cr
Other Receivables	46Cr	39Cr	25Cr	9.1Cr	41Cr
Notes Receivable	-	-	97Cr	16.97L	51.56L
Total Receivables	478.24Cr	494.02Cr	627.11Cr	178.39Cr	205.76Cr
Inventory	375.67Cr	428.5Cr	438.6Cr	10Cr	114.18Cr
Prepaid Expenses	2.18Cr	5.03Cr	4.07Cr	-	1.01Cr
Other Current Assets, Total	76Cr	127.35Cr	77Cr	40Cr	77Cr
Total Current Assets	944.18Cr	1.08TCr	1.16TCr	661.13Cr	865.35Cr
Gross Property Plant And Equipment	1.31TCr	1.33TCr	1.34TCr	8.13Cr	568.16Cr
Accumulated Depreciation	-563.38Cr	-691.4Cr	-745.86Cr	-2.77Cr	-308.09Cr
Net Property Plant And Equipment	748.09Cr	636.84Cr	592.75Cr	5.36Cr	260.07Cr
Long-term Investments	36Cr	29Cr	30Cr	110.54Cr	174.09Cr
Goodwill	21.13L	4L	-	-	-
Other Intangibles, Total	9.2Cr	1Cr	-	-	11Cr
Loans Receivable Long-Term	-	-	-	353.43Cr	74Cr
Deferred Tax Assets Long-Term	60Cr	52Cr	30Cr	32Cr	45Cr
Other Long-Term Assets, Total	21Cr	5.62Cr	6.6Cr	2.79Cr	9.96Cr
Total Assets	1.82TCr	1.8TCr	1.82TCr	1.17TCr	1.44TCr
Liabilities
Accounts Payable, Total	138.82Cr	175.95Cr	203.99Cr	94Cr	110.23Cr
Accrued Expenses, Total	20Cr	19Cr	21Cr	9.97Cr	66Cr
Short-term Borrowings	73Cr	64Cr	49Cr	2.71Cr	5.55Cr
Current Portion of Long-Term Debt	48Cr	41Cr	60Cr	2.75Cr	9.35Cr
Current Portion of Leases	3L	3L	3L	-	2L
Current Income Taxes Payable	98.01L	5.39Cr	12Cr	101.79Cr	4.21Cr
Unearned Revenue Current, Total	3L	3L	3L	-	-
Other Current Liabilities	34Cr	30Cr	25Cr	10Cr	25Cr
Total Current Liabilities	314.52Cr	334.5Cr	371.09Cr	221.28Cr	220.58Cr
Long-Term Debt	884.13Cr	847.78Cr	752.6Cr	11Cr	26Cr
Long-Term Leases	48.21L	50.62L	53.25L	-	22.71L
Unearned Revenue Non Current	17.41L	14.87L	12.34L	-	7.49Cr
Pension & Other Post Retirement Benefits	13Cr	14Cr	15Cr	1.03Cr	9.13Cr
Other Non Current Liabilities	3.18Cr	3.02Cr	2.94Cr	19.47L	2.24Cr
Total Liabilities	1.22TCr	1.2TCr	1.14TCr	233.67Cr	265.37Cr
Common Stock, Total	59Cr	59Cr	59Cr	59Cr	69Cr
Additional Paid In Capital	307.31Cr	307.31Cr	307.31Cr	307.31Cr	395.4Cr
Retained Earnings	61Cr	74Cr	135.6Cr	568.84Cr	135.47Cr
Comprehensive Income and Other	175.76Cr	160.78Cr	179.93Cr	-3.78Cr	573.39Cr
Total Common Equity	603.51Cr	600.97Cr	681.93Cr	931.46Cr	1.17TCr
Minority Interest	-9L	-11.02L	-	-2L	-3L
Total Equity	603.42Cr	600.86Cr	681.93Cr	931.44Cr	1.17TCr
Total Liabilities And Equity	1.82TCr	1.8TCr	1.82TCr	1.17TCr	1.44TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.91Cr	5.91Cr	5.91Cr	5.91Cr	6.87Cr
ECS Total Common Shares Outstanding	5.91Cr	5.91Cr	5.91Cr	5.91Cr	6.87Cr
Book Value / Share	102.14	101.71	115.41	157.64	170.63
Tangible Book Value	594.09Cr	599.94Cr	681.93Cr	931.46Cr	1.16TCr
Tangible Book Value Per Share	100.55	101.53	115.41	157.64	169.08
Total Debt	1.01TCr	953.02Cr	862.1Cr	17Cr	41Cr
Net Debt	993.75Cr	931.54Cr	843.9Cr	-415.31Cr	-426.55Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	14Cr	17Cr	18Cr	-18Cr	11Cr
Debt Equivalent Oper. Leases	4.3Cr	4.13Cr	5.96Cr	6.91Cr	13Cr
Minority Interest, Total (Incl. Fin. Div)	-9L	-11.02L	-	-2L	-3L
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	94Cr	108.49Cr	108.23Cr	21.83L	82Cr
Inventories - Work In Process, Total	165.67Cr	191.42Cr	189.28Cr	-	10Cr
Inventories - Finished Goods, Total	106.64Cr	117.13Cr	128.19Cr	10Cr	21Cr
Inventories - Others	9.18Cr	11Cr	13Cr	-	1.59Cr
Land - (BS)	54Cr	54Cr	54Cr	-	26Cr
Buildings, Total	267.47Cr	268.69Cr	269.67Cr	-	137.11Cr
Machinery, Total	977.25Cr	994.22Cr	1.01TCr	8.13Cr	377.64Cr
Full Time Employees	1.53T	1.45T	1.5T	47	1.25T
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	53Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-3.15Cr	-2.15Cr	48Cr	420.96Cr	250.48Cr
Depreciation & Amortization - CF	55Cr	129.98Cr	57Cr	53Cr	22Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	74T
Depreciation & Amortization, Total	55Cr	129.98Cr	57Cr	53Cr	22Cr
Amortization of Deferred Charges, Total - (CF)	32Cr	1.06Cr	-	-	2.4Cr
(Gain) Loss From Sale Of Asset	-	3.01Cr	1.06Cr	23Cr	-29Cr
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	25Cr	1.67Cr
Other Operating Activities, Total	113.21Cr	106.3Cr	139.93Cr	-201.63Cr	-253.62Cr
Change In Accounts Receivable	-38Cr	-26Cr	-37Cr	-112.24Cr	97Cr
Change In Inventories	-33Cr	-53Cr	-10Cr	33Cr	-43Cr
Change In Income Taxes	64.02L	-	-	-	-
Change in Other Net Operating Assets	8.25Cr	-8.91Cr	-4.54Cr	-403.69Cr	-73Cr
Cash from Operations	134.95Cr	150.27Cr	194.62Cr	-163.12Cr	-25Cr
Capital Expenditure	-3.91Cr	-18Cr	-13Cr	-45Cr	-64Cr
Sale of Property, Plant, and Equipment	-	5.5Cr	14.47L	2.95Cr	39Cr
Sale (Purchase) of Intangible assets	-48.62L	-	-	-	-
Investment in Marketable and Equity Securities, Total	-6.29Cr	17Cr	-1.27Cr	-81Cr	-125.83Cr
Other Investing Activities, Total	51.28L	56.21L	53.1L	18Cr	42Cr
Cash from Investing	-10Cr	4.77Cr	-13Cr	-104.32Cr	-109.62Cr
Short Term Debt Issued, Total	-	-	-	-	28Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	28Cr
Long-Term Debt Repaid, Total	-40Cr	-36Cr	-46Cr	-37Cr	-6.6Cr
Total Debt Repaid	-40Cr	-36Cr	-46Cr	-37Cr	-6.6Cr
Issuance of Common Stock	-	-	-	-	93Cr
Other Financing Activities, Total	-84Cr	-104.87Cr	-139.75Cr	736.34Cr	-44Cr
Cash from Financing	-123.75Cr	-140.88Cr	-185.66Cr	698.91Cr	69Cr
Miscellaneous Cash Flow Adjustments	-	-	-1T	-	-
Net Change in Cash	1.03Cr	14Cr	-4.41Cr	431.48Cr	-66Cr
Supplemental Items
Cash Interest Paid	84Cr	104.87Cr	128.52Cr	126.05Cr	42Cr
Cash Income Tax Paid (Refund)	-	-	11Cr	73Cr	3.22Cr
Levered Free Cash Flow	24Cr	27Cr	44Cr	984.81Cr	-209.97Cr
Unlevered Free Cash Flow	83Cr	84Cr	98Cr	1.01TCr	-209.1Cr
Change In Net Working Capital	69Cr	86Cr	60Cr	-870.81Cr	141.77Cr
Net Debt Issued / Repaid	-40Cr	-36Cr	-46Cr	-37Cr	21Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.76	3.19	6.26	8.99	-1.89
Return on Total Capital	4.23	3.65	7.32	10.79	-2.44
Return On Equity %	-0.51	-0.36	7.42	52.18	25.24
Return on Common Equity	-0.51	-0.36	7.42	52.18	25.24
Margin Analysis
Gross Profit Margin %	50.21	49.95	46.08	49.01	48.74
SG&A Margin	11.89	10.94	11.52	12.2	22.28
EBITDA Margin %	18.32	21.13	19.64	20.68	-3.88
EBITA Margin %	12.24	8.78	14.93	16.58	-7.81
EBIT Margin %	12.24	8.78	14.93	16.58	-7.81
Income From Continuing Operations Margin %	-0.35	-0.2	3.91	32.45	44.59
Net Income Margin %	-0.35	-0.2	3.91	32.45	44.59
Net Avail. For Common Margin %	-0.35	-0.2	3.91	32.45	44.59
Normalized Net Income Margin	1.24	1.56	5.86	9.27	0.65
Levered Free Cash Flow Margin	2.7	2.56	3.62	75.91	-37.38
Unlevered Free Cash Flow Margin	9.13	7.99	8.06	78.16	-37.23
Asset Turnover
Asset Turnover	0.49	0.58	0.67	0.87	0.39
Fixed Assets Turnover	1.17	1.52	1.98	4.34	2.29
Receivables Turnover (Average Receivables)	2.15	2.34	2.51	3.8	2.35
Inventory Turnover (Average Inventory)	1.26	1.31	1.51	2.95	3.05
Short Term Liquidity
Current Ratio	3	3.22	3.14	2.99	3.92
Quick Ratio	1.56	1.54	1.48	2.76	3.05
Operating Cash Flow to Current Liabilities	0.43	0.45	0.52	-0.74	-0.12
Days Sales Outstanding (Average Receivables)	169.7	155.87	145.13	96.36	155.14
Days Outstanding Inventory (Average Inventory)	290.45	278.7	241.38	124.24	119.61
Average Days Payable Outstanding	103.27	99.14	104.16	233.71	224.59
Cash Conversion Cycle (Average Days)	356.88	335.43	282.35	-13.12	50.16
Long Term Solvency
Total Debt/Equity	166.61	158.61	126.42	1.78	3.48
Total Debt / Total Capital	62.49	61.33	55.83	1.75	3.37
LT Debt/Equity	146.6	141.18	110.44	1.2	2.21
Long-Term Debt / Total Capital	54.99	54.59	48.78	1.18	2.14
Total Liabilities / Total Assets	66.82	66.63	62.61	20.06	18.45
EBIT / Interest Expense	1.19	1.01	2.1	4.61	-31.71
EBITDA / Interest Expense	1.78	2.43	2.77	5.75	-15.75
(EBITDA - Capex) / Interest Expense	1.74	2.23	2.62	4.79	-62.32
Total Debt / EBITDA	6.05	4.29	3.61	0.06	-1.88
Net Debt / EBITDA	5.98	4.19	3.53	-1.55	19.59
Total Debt / (EBITDA - Capex)	6.2	4.67	3.81	0.07	-0.47
Net Debt / (EBITDA - Capex)	6.13	4.57	3.73	-1.86	4.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.44	16.03	15.48	6.69	-67.14
Gross Profit, 1 Yr. Growth %	13.07	15.42	8.7	13.46	-67.38
EBITDA, 1 Yr. Growth %	1.27	12.16	6.89	12.33	-107.11
EBITA, 1 Yr. Growth %	50.03	-16.72	96.4	18.46	-119.41
EBIT, 1 Yr. Growth %	50.03	-16.72	96.4	18.46	-119.42
Earnings From Cont. Operations, 1 Yr. Growth %	-85.15	-31.72	-2.31T	784.44	-53.51
Net Income, 1 Yr. Growth %	-85.15	-31.72	-2.31T	784.44	-53.51
Normalized Net Income, 1 Yr. Growth %	-190.79	45.48	335.12	68.81	-96.5
Diluted EPS Before Extra, 1 Yr. Growth %	-87.57	-31.72	-2.31T	784.38	-61.38
Accounts Receivable, 1 Yr. Growth %	9.07	5.18	11.11	-66.53	-47.43
Inventory, 1 Yr. Growth %	9.58	14.06	2.36	-97.62	53.16
Net Property, Plant and Equip., 1 Yr. Growth %	-6.31	-14.87	-6.92	-99.1	13.01
Total Assets, 1 Yr. Growth %	-2.76	-0.97	1.29	-36.13	-1.51
Tangible Book Value, 1 Yr. Growth %	-0.92	0.98	13.66	36.59	45.01
Common Equity, 1 Yr. Growth %	-5.8	-0.42	13.47	36.59	44.44
Cash From Operations, 1 Yr. Growth %	7.75	11.36	29.51	-183.81	-86.38
Capital Expenditures, 1 Yr. Growth %	-63.6	370.92	-30.65	248.59	-11.79
Levered Free Cash Flow, 1 Yr. Growth %	-0.1	10	57.48	2.14T	-122.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-6.46	1.52	15.14	935.12	-121.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.89	14.73	15.8	11	-32.03
Gross Profit, 2 Yr. CAGR %	10.09	14.24	10.93	11.06	-30.1
EBITDA, 2 Yr. CAGR %	5.75	16.44	9.76	9.58	-69.81
EBITA, 2 Yr. CAGR %	57.93	11.78	27.9	52.53	-50.85
EBIT, 2 Yr. CAGR %	57.93	11.78	27.9	52.53	-50.85
Earnings From Cont. Operations, 2 Yr. CAGR %	-67.03	-68.15	288.89	1.3T	129.4
Net Income, 2 Yr. CAGR %	-67.03	-68.15	288.89	1.3T	129.4
Normalized Net Income, 2 Yr. CAGR %	-26.38	14.92	151.6	171.03	-77.4
Diluted EPS Before Extra, 2 Yr. CAGR %	-70.11	-70.86	288.89	1.3T	109.07
Accounts Receivable, 2 Yr. CAGR %	11.01	7.11	8.1	-39.02	-42.94
Inventory, 2 Yr. CAGR %	8.93	11.8	8.05	-84.38	-48.98
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.9	-10.69	-10.99	-90.82	-33.76
Total Assets, 2 Yr. CAGR %	-2.78	-1.87	0.15	-19.56	-11.2
Tangible Book Value, 2 Yr. CAGR %	7.75	0.03	7.14	24.6	30.55
Common Equity, 2 Yr. CAGR %	1.33	-3.15	6.3	24.5	31.15
Cash From Operations, 2 Yr. CAGR %	44.76	9.54	20.09	4.18	-63.82
Capital Expenditures, 2 Yr. CAGR %	-49.37	30.92	80.72	55.48	124.57
Levered Free Cash Flow, 2 Yr. CAGR %	-52.7	4.83	34.09	493.94	118.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.72	-2.55	8.77	245.24	46.1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.29	10.54	15.01	12.68	-18.9
Gross Profit, 3 Yr. CAGR %	5.63	11.84	11.64	11.77	-19.02
EBITDA, 3 Yr. CAGR %	3.74	14.4	13.35	10.61	-53.98
EBITA, 3 Yr. CAGR %	21.32	27.59	34.89	24.68	-22
EBIT, 3 Yr. CAGR %	21.32	27.59	34.89	24.68	-22
Earnings From Cont. Operations, 3 Yr. CAGR %	-47.68	-57.97	30.97	411.41	388.48
Net Income, 3 Yr. CAGR %	-47.68	-57.97	30.97	411.41	388.48
Normalized Net Income, 3 Yr. CAGR %	-21.98	-7.61	79.12	120.26	-39.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-52.2	-60.64	23.43	411.4	359.17
Accounts Receivable, 3 Yr. CAGR %	1.97	9.03	8.42	-26.87	-28.75
Inventory, 3 Yr. CAGR %	5.83	10.61	8.56	-69.69	-35.65
Net Property, Plant and Equip., 3 Yr. CAGR %	-4.7	-8.99	-9.45	-80.72	-25.81
Total Assets, 3 Yr. CAGR %	-3.49	-2.18	-0.83	-13.79	-7.22
Tangible Book Value, 3 Yr. CAGR %	11.61	5.45	4.38	16.17	24.66
Common Equity, 3 Yr. CAGR %	2.94	0.74	2.1	15.57	24.97
Cash From Operations, 3 Yr. CAGR %	22.68	32.64	15.83	6.52	-44.66
Capital Expenditures, 3 Yr. CAGR %	-42.39	6.47	5.93	124.96	51.79
Levered Free Cash Flow, 3 Yr. CAGR %	-35.12	-37.33	21.56	242.78	95.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.01	13.95	3.44	130.5	34.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.43	8.06	9.37	10.74	-6.81
Gross Profit, 5 Yr. CAGR %	7.91	10.29	7.72	11.1	-7.43
EBITDA, 5 Yr. CAGR %	7.05	12.62	9.93	12.55	-33.22
EBITA, 5 Yr. CAGR %	27.14	21.78	23.91	37.04	-9.93
EBIT, 5 Yr. CAGR %	27.14	21.78	23.91	37.04	-9.92
Earnings From Cont. Operations, 5 Yr. CAGR %	-44.3	-44.03	16.71	70.82	63.88
Net Income, 5 Yr. CAGR %	-44.3	-44.03	16.71	70.82	63.88
Normalized Net Income, 5 Yr. CAGR %	-23.71	-12.1	24.62	42.09	-21.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-48.24	-47.59	10.56	64.23	52.39
Accounts Receivable, 5 Yr. CAGR %	3.03	4.94	4.38	-13.58	-16.13
Inventory, 5 Yr. CAGR %	1.08	4.52	6.72	-49.44	-19.74
Net Property, Plant and Equip., 5 Yr. CAGR %	-4.58	-6.54	-7.26	-63.65	-20.1
Total Assets, 5 Yr. CAGR %	-3.86	-3.37	-2.05	-9.54	-5.11
Tangible Book Value, 5 Yr. CAGR %	15.51	13.06	9.8	12.73	14.16
Common Equity, 5 Yr. CAGR %	3.13	2.49	4.27	9.64	12.86
Cash From Operations, 5 Yr. CAGR %	11.18	9.48	21.64	20.43	-27.28
Capital Expenditures, 5 Yr. CAGR %	-31.31	-1.83	-8.99	23.89	43.07
Levered Free Cash Flow, 5 Yr. CAGR %	6.25	-35.08	-13.26	55.22	53.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.06	-21.38	-1.63	77.96	18.76